Download - Pharmacovigilance Risk-benefit optimisation … November 2010 Pharmacovigilance Regulatory Science Risk Management Risk-benefit optimisation Advanced Therapies Biologics ... November

Transcript

www.pharminvent.com November2010

Pharmacovigilance

Regulatory Science

Risk Management

Risk-benefit optimisation

Advanced Therapies

Biologics

Biosimilars

Generics

Small molecules

Centrally authorised

Decentralised procedures

Mutually recognised

Nationally authorised

www.pharminvent.com November2010

PharmInvent is led by experienced

EU ex-regulators, including former

members of CHMP and PhVWP, EMA

managers, as well as ICH and CIOMS

expert group members.